mylan inc (MYL:NASDAQ GS)

Executive Profile*

Background*

Mr. Rajiv Malik has been the President at Mylan, Inc. since January 1, 2012. Mr. Malik serves as Company Secretary at ANG Auto Ltd. Mr. Malik served as Senior Vice President and Head of Business Operations at Advinus Therapeutics Private Limited. Mr. Malik served as the Chief Operating Officer of Mylan, Inc. from July 2009 to January 1, 2012 and as its Executive Vice President from October 2007 to January 1, 2012. He has over 17 years of experience in managing business ... operations including last 6 years in Pharmaceutical R&D environment. Mr. Malik served as Head of Operations at Advinus Therapeutics Private Limited. Prior to joining Advinus, he has held several senior positions with top companies in India and has varied experience of working with Pharmaceutical, Biotech, FMCG and IT sectors. He served as Chief Executive Officer of Matrix Laboratories Limited from February 1, 2007 to February 28, 2008, its Managing Director from February 1, 2007 to July 1, 2008 and served as its Chief Executive Director since February 1, 2007. He served as Head, Global Technical Operations of Mylan Laboratories. Mr. Malik served as Head of Global Technical Operations of Mylan, Inc., a subsidiary of Matrix Laboratories Limited from January 31, 2007 to July, 2009. Prior to joining Matrix, Mr. Malik served as an Associate of Sandoz, the global generics arm of Novartis, as its Head of Global Development and Registration. Before joining Sandoz in 2003, he served as Vice President and Head of Pharma Research and Global Regulatory Affairs of Ranbaxy Laboratories Ltd. He had a 20 year experience with Ranbaxy Laboratories. He has over 24 years of rich experience in global generic pharmaceutical industry. He has been Director of Mylan, Inc. since February 11, 2013. He has been a Non-Executive Director of Mylan Laboratories Limited (Former Name: Matrix Laboratories Limited) since July 1, 2008. He has about 60 formulation process patents and 10 publications in pharmaceutical journals to his credit. He serves as a Member of the Regulatory Affairs Professional Society, USA. Mr. Malik studied Master degree in Pharmacy Pharmaceutical Technology from Punjab University and has an Master degree in Business Administration (MBA) from Drexel University, Philadelphia, U.S.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
MYL:US	$31.40 USD	+0.70

COMPETITOR COMPENSATION